Antivirale Medikamente: Potente Wirkstoffe, Hoffnungsträger bei COVID‑19 und therapeutische Grenzen

Antiviral drugs inhibit viral replication by interaction with specific elements of the viral replication cycle. Directly acting antiviral agents have revolutionized the therapeutic options for chronic infections with human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (...

Descripción completa

Detalles Bibliográficos
Autores principales: Malin, Jakob J., Bunse, Till, Spinner, Christoph D., Protzer, Ulrike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2022
Materias:
Arzneimitteltherapie
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730307/
https://www.ncbi.nlm.nih.gov/pubmed/34988607
http://dx.doi.org/10.1007/s00108-021-01233-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730307/
https://www.ncbi.nlm.nih.gov/pubmed/34988607
http://dx.doi.org/10.1007/s00108-021-01233-4

Ejemplares similares